Cargando…

TLR7 Signaling Drives the Development of Sjögren’s Syndrome

Sjögren’s syndrome (SS) is a chronic systemic autoimmune disease that affects predominately salivary and lacrimal glands. SS can occur alone or in combination with another autoimmune disease like systemic lupus erythematosus (SLE). Here we report that TLR7 signaling drives the development of SS sinc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yawen, Roussel-Queval, Annie, Chasson, Lionel, Hanna Kazazian, Noël, Marcadet, Laetitia, Nezos, Andrianos, Sieweke, Michael H., Mavragani, Clio, Alexopoulou, Lena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183380/ https://www.ncbi.nlm.nih.gov/pubmed/34108972 http://dx.doi.org/10.3389/fimmu.2021.676010

Ejemplares similares

Lupus Autoimmunity and Metabolic Parameters Are Exacerbated Upon High Fat Diet-Induced Obesity Due to TLR7 Signaling
por: Hanna Kazazian, Noël, et al.
Publicado: (2019)

Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis
por: Nezos, Adrianos, et al.
Publicado: (2015)

Study of the incidence of osteoporosis in patients with Sjögren’s syndrome (pSS) and investigation of activation of the RANKL /RANK and osteoprotegerin (OPG) system
por: Skarlis, Charalampos, et al.
Publicado: (2018)

Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren’s syndrome: prevalence, clinical and laboratory associations
por: Gravani, Fotini, et al.
Publicado: (2015)

Milk Fat Globule Epidermal Growth Factor 8 (MFGE8) Gene Variants in Rheumatoid Arthritis and Sjögren’s Syndrome
por: Skarlis, Charalampos, et al.
Publicado: (2022)

TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome Patients
por: Nezos, Adrianos, et al.
Publicado: (2018)

Sex Bias in Susceptibility to MCMV Infection: Implication of TLR9
por: Traub, Stephanie, et al.
Publicado: (2012)

Editorial: Management of Sjögren's Syndrome
por: Alunno, Alessia, et al.
Publicado: (2022)

Sjogren’s Syndrome: Recent Updates
por: Skarlis, Charalampos, et al.
Publicado: (2022)

+3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications
por: Skarlis, Charalampos, et al.
Publicado: (2021)

Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren’s Syndrome
por: Argyriou, Evangelia, et al.
Publicado: (2021)

Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use
por: Fragkioudaki, Sofia, et al.
Publicado: (2016)

B-cell Activating Factor Polymorphisms in Rheumatoid Arthritis-Associated Atherosclerosis
por: Kintrilis, Nikolaos, et al.
Publicado: (2021)

Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren’s Syndrome-Related Lymphoma?
por: Nezos, Adrianos, et al.
Publicado: (2021)

MTHFR gene variants and non-MALT lymphoma development in primary Sjogren’s syndrome
por: Fragkioudaki, Sofia, et al.
Publicado: (2017)

Osteoprotegerin and MTHFR gene variations in rheumatoid arthritis: association with disease susceptibility and markers of subclinical atherosclerosis
por: Arida, Aikaterini, et al.
Publicado: (2022)

Musculoskeletal Manifestations in Sjogren’s Syndrome: An Orthopedic Point of View
por: Rozis, Meletios, et al.
Publicado: (2021)

Vitamin D Deficiency in Primary Sjögren’s Syndrome: Association with Clinical Manifestations and Immune Activation Markers
por: Athanassiou, Panagiotis, et al.
Publicado: (2022)

Nucleic acid-sensing toll-like receptors: Important players in Sjögren’s syndrome
por: Alexopoulou, Lena
Publicado: (2022)

Predicting the Outcome of Sjogren’s Syndrome-Associated Non-Hodgkin’s Lymphoma Patients
por: Papageorgiou, Aristea, et al.
Publicado: (2015)

The Role of Novel Autoantibodies in the Diagnostic Approach and Prognosis of Patients with Raynaud’s Phenomenon
por: Koulouri, Vasiliki, et al.
Publicado: (2020)

Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity
por: Karathanasis, Dimitris K., et al.
Publicado: (2022)

Scleroderma specific autoantibodies in rheumatoid arthritis and Sjögren's syndrome patients with interstitial lung disease: Prevalence and associations
por: Koulouri, Vasiliki, et al.
Publicado: (2022)

Association Between DNA Damage Response, Fibrosis and Type I Interferon Signature in Systemic Sclerosis
por: Vlachogiannis, Nikolaos I., et al.
Publicado: (2020)

Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sjögren’s Syndrome
por: Flessa, Christina-Maria, et al.
Publicado: (2022)

Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus
por: Ntouros, Panagiotis A., et al.
Publicado: (2021)

TLR7 agonism accelerates disease in a mouse model of primary Sjögren’s syndrome and drives expansion of T-bet(+) B cells
por: Punnanitinont, Achamaporn, et al.
Publicado: (2022)

Prevalence and Clinical Implications of Scleroderma-Specific Autoantibodies in Seronegative Patients with Sicca Complaints
por: Marketos, Nikolaos, et al.
Publicado: (2023)

A case of antisynthetase syndrome
por: Mavragani, Clio P., et al.
Publicado: (2020)

Flow cytometry and immunohistochemistry of the mouse dural meninges for immunological and virological assessments
por: Roussel-Queval, Annie, et al.
Publicado: (2023)

Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome
por: Fava, Roy A, et al.
Publicado: (2011)

Role of TLR3 in the immunogenicity of replicon plasmid-based vaccines
por: Diebold, Sandra S., et al.
Publicado: (2008)

The Immunomodulatory Properties of Vitamin D
por: Athanassiou, Lambros, et al.
Publicado: (2022)

Editorial: Demyelinating neurological syndromes: The role of autoimmunity
por: Evangelopoulos, Maria Eleftheria, et al.
Publicado: (2023)

Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies
por: Mavragani, Clio P., et al.
Publicado: (2012)

Polyarthritis and Psoriasiform Skin Lesions following Pembrolizumab Therapy
por: Koulouri, Vasiliki, et al.
Publicado: (2021)

Activation of Type I Interferon Pathway in Systemic Lupus Erythematosus: Association with Distinct Clinical Phenotypes
por: Karageorgas, Theophanis P., et al.
Publicado: (2011)

Anxiety and Extraversion in Lupus-Related Atherosclerosis
por: Giannelou, Maira, et al.
Publicado: (2018)

Innate Immune Response to Streptococcus pyogenes Depends on the Combined Activation of TLR13 and TLR2
por: Fieber, Christina, et al.
Publicado: (2015)

The Roles of RANK/RANKL/OPG in Cardiac, Skeletal, and Smooth Muscles in Health and Disease
por: Marcadet, Laetitia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bt772mmoonrrsvcc351g9sehip